Clinical Trial Update: Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating valopicitabine alone and in combination with interferon in treatment-naive patients with chronic hepatitis C; the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon (interferon)
• Valopicitabine (valopicitabine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C | Phase 1, Phase 2 | Status: COMPLETED